September 27, 2016
The future of pharma is going to involve some major culture shifts for a business that has long been focused on slow development cycles, proprietary molecules, and close-held secrets. That’s the word from representatives from Bayer, Boehringer Ingelheim, Healthware International and BTG, a group that ran the gamut from small to big pharma at yesterday’s Pharma Roundtable onsite at Health 2.0 in...
January 12, 2015
Qualcomm is already one of the biggest investors in digital health, according to Rock Health.
Qualcomm and Novartis, which announced a partnership just last week for mobile-enabled clinical trials, will also be banding together to start an investment firm, the companies announced ahead of the JP Morgan Healthcare event this week. Qualcomm Ventures and Novartis will leverage up to $100 million...
July 14, 2014
When it comes to digital health, pharmaceutical companies tend to be slow and cautious, because of the onerous risks they face from the FDA should they improperly market a drug via the internet or mobile channels. But big pharma recognizes the need to innovate and stay on top of the times as well. That’s why the trend lately has been for large pharmaceutical companies to spin out a smaller group...